AI Article Synopsis

  • Histone deacetylase (HDAC) inhibitors are being researched for cancer treatment because they can stop the cell cycle in cancer cells.
  • The study used a technique to find small molecule suppressors, called ITSAs, that can reverse the cell cycle arrest and histone modifications caused by the HDAC inhibitor trichostatin A (TSA).
  • While ITSAs counteract TSA's effects, including tubulin acetylation, this modification may not directly affect cell cycle progression but could be important for other cellular functions.

Article Abstract

Histone deacetylase (HDAC) inhibitors are being developed as new clinical agents in cancer therapy, in part because they interrupt cell cycle progression in transformed cell lines. To examine cell cycle arrest induced by HDAC inhibitor trichostatin A (TSA), a cytoblot cell-based screen was used to identify small molecule suppressors of this process. TSA suppressors (ITSAs) counteract TSA-induced cell cycle arrest, histone acetylation, and transcriptional activation. Hydroxamic acid-based HDAC inhibitors like TSA and suberoylanilide hydroxamic acid (SAHA) promote acetylation of cytoplasmic alpha-tubulin as well as histones, a modification also suppressed by ITSAs. Although tubulin acetylation appears irrelevant to cell cycle progression and transcription, it may play a role in other cellular processes. Small molecule suppressors such as the ITSAs, available from chemical genetic suppressor screens, may prove to be valuable probes of many biological processes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1074-5521(03)00093-0DOI Listing

Publication Analysis

Top Keywords

cell cycle
16
small molecule
12
chemical genetic
8
tubulin acetylation
8
hdac inhibitors
8
cycle progression
8
cycle arrest
8
molecule suppressors
8
suppressors itsas
8
cell
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!